Related Experiment Videos
Evaluating coverage of genome-wide association studies
Jeffrey C Barrett1, Lon R Cardon
1Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Nature Genetics
|May 23, 2006
Summary
Genome-wide association studies (GWAS) face challenges in selecting single nucleotide polymorphisms (SNPs). Predefined marker panels offer substantial genome coverage for common variation in non-African populations, but effectiveness varies with allele frequencies and study design.
Area of Science:
- Genetics
- Genomics
- Population Genetics
Background:
- Genome-wide association studies (GWAS) are increasingly utilizing hundreds of thousands of single nucleotide polymorphisms (SNPs).
- Selecting appropriate SNPs for genotyping is a critical early challenge in GWAS design.
- Predefined, commercially available marker panels are commonly used for first-generation genome-wide scans due to practicality.
Purpose of the Study:
- To compare different SNP selection approaches for genome-wide association studies.
- To evaluate the genome coverage provided by first-generation high-throughput genotyping platforms.
Main Methods:
- Comparison of various SNP selection strategies.
- Assessment of genome coverage for common variation in non-African populations.
- Analysis of factors influencing coverage, including allele frequencies and study design.
Main Results:
- Many current SNP selection methods provide substantial coverage of common genetic variation in non-African populations.
- The precise extent of genome coverage is significantly influenced by allele frequencies and specific study design considerations.
- First-generation high-throughput genotyping platforms demonstrate comparable genome coverage despite variations in technology and marker selection.
Conclusions:
- The choice of SNPs is a crucial factor impacting the success of genome-wide association studies.
- While predefined marker panels offer broad coverage, their efficacy is nuanced and depends on specific genetic and design parameters.
- Current high-throughput platforms provide similar genome coverage, suggesting a degree of standardization in early GWAS efforts.